Home › Trial NCT01733147
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
- Trial IDNCT01733147
- StatusCompleted
- PhasePhase 4
- Study typeInterventional
- SponsorMayo Clinic
- Enrollment60
- Start date2012-11
- ConditionsBarrett's Esophagus · Obesity
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.